Profiting with vision care plans

Article

During the American Optometric Association’s Optometry’s Meeting, Jay Binkowtiz, CEO of Gateway Professional Network, shared his tips for being profitable in the age of managed vision care plans.

Philadelphia-Jay Binkowtiz, CEO of Gateway Professional Network, shared his tips for being profitable in the age of managed vision care plans.

Says Binkowitz: "It is absurd that practices are still following the outdated three-times mark-up strategy." Instead, practices should be focused on pricing based on fair market value.

“I really don’t care what some company says I should sell something for,” he says.

You need to do some research and figure out what is the ideal pricing for your area and your practice, Binkowitz says.

When explaining a patient’s benefits, Binkowitz says many staffers think they need to explain exactly what the patient is getting and exactly what she’s paying for, which he refers to as “billing language.” But he approaches it in a different way by talking about the total price and explaining the amount she’ll save with her vision coverage.

“Do you know what consumers do when you subtract and tell them how much money they’ll save? They spend money,” he says.

For example, Binkowitz has the following conversation with his patients: “The regular cost of these lenses is ­­____. But we have it all packaged for you at ____. That is a savings of ____. We really want to sure you have what you need.”

When explaining the final savings to a patient, emphasize that she has a great vision care plan, he says.

Binkowitz also recommends:

• Eliminate “no,” “can’t,” “won’t,” and “don’t” from your vocabulary.

• Invest in an edger and use stock lenses. (“If you don’t have an edger, you can’t make money,” he says.)

• Inform the patient about any warranties right after you introduce yourself. (“You need her to know that when she spends money, it’s going to be protected,” he says.)

• Look for opportunities to increase the sale as soon as possible. (“LensCrafters is successful at selling second pairs because it sells the second pair first, before even addressing the patient’s initial need,” he says.)

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.